Prostate Cancer
Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer.
January 3, 2023
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.
January 3, 2023
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
January 3, 2023
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
January 2, 2023
MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
January 2, 2023
Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy.
December 30, 2022
Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER-based study.
December 30, 2022
18F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer.
December 30, 2022
A pilot study of MRI radiomics for high-risk prostate cancer stratification in 1.5 T MR-guided radiotherapy.
December 29, 2022
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOARĀ® system.
December 29, 2022
Conditional gene regulation models demonstrate a pro-proliferative role for growth hormone receptor in prostate cancer.
December 29, 2022
Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations.
December 29, 2022